Correlates of Protection Induced by Vaccination

被引:1219
作者
Plotkin, Stanley A. [1 ,2 ]
机构
[1] Vaxconsult, Doylestown, PA 18902 USA
[2] Univ Penn, Doylestown, PA 18902 USA
关键词
INFLUENZAE TYPE-B; T-CELL RESPONSES; PNEUMOCOCCAL CONJUGATE VACCINE; HUMAN-IMMUNODEFICIENCY-VIRUS; VARICELLA-ZOSTER-VIRUS; YELLOW-FEVER VACCINE; HEPATITIS-B; CAPSULAR POLYSACCHARIDE; ANTIBODY-RESPONSES; IMMUNE-RESPONSES;
D O I
10.1128/CVI.00131-10
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This paper attempts to summarize current knowledge about immune responses to vaccines that correlate with protection. Although the immune system is redundant, almost all current vaccines work through antibodies in serum or on mucosa that block infection or bacteremia/viremia and thus provide a correlate of protection. The functional characteristics of antibodies, as well as quantity, are important. Antibody may be highly correlated with protection or synergistic with other functions. Immune memory is a critical correlate: effector memory for short-incubation diseases and central memory for long-incubation diseases. Cellular immunity acts to kill or suppress intracellular pathogens and may also synergize with antibody. For some vaccines, we have no true correlates, but only useful surrogates, for an unknown protective response.
引用
收藏
页码:1055 / 1065
页数:11
相关论文
共 205 条
  • [31] 12-YEAR FOLLOW-UP-STUDY OF HEPATITIS-B IMMUNIZATION OF SENEGALESE INFANTS
    COURSAGET, P
    LEBOULLEUX, D
    SOUMARE, M
    LECANN, P
    YVONNET, B
    CHIRON, JP
    COLLSECK, AM
    DIOPMAR, I
    [J]. JOURNAL OF HEPATOLOGY, 1994, 21 (02) : 250 - 254
  • [32] Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus
    Dagan, R
    Givon-Lavi, N
    Fraser, D
    Lipsitch, M
    Siber, GR
    Kohberger, R
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (03) : 367 - 376
  • [33] NATURAL OR VACCINE-INDUCED ANTIBODY AS A PREDICTOR OF IMMUNITY IN THE FACE OF NATURAL CHALLENGE WITH INFLUENZA-VIRUSES
    DAVIES, JR
    GRILLI, EA
    [J]. EPIDEMIOLOGY AND INFECTION, 1989, 102 (02) : 325 - 333
  • [34] Mumps Outbreaks in Vaccinated Populations: Are Available Mumps Vaccines Effective Enough to Prevent Outbreaks?
    Dayan, Gustavo H.
    Rubin, Steven
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 47 (11) : 1458 - 1467
  • [35] NEONATAL TETANUS DESPITE IMMUNIZATION AND PROTECTIVE ANTITOXIN ANTIBODY
    DEMORAESPINTO, MI
    ORUAMABO, RS
    IGBAGIRI, FP
    CHAN, MCK
    PRADO, SMA
    VANCETTO, MDC
    JOHNSON, PM
    HART, CA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) : 1076 - 1077
  • [36] Dietzschold B, 2005, CURR TOP MICROBIOL, V292, P45
  • [37] Relationship between structure and neutralizing activity of rabbit tetanus antibodies elicited by acellular and whole-cell pertussis DTP vaccines
    Dokmetjian, J
    Della Valle, C
    Lavigne, V
    Eriksson, PV
    Manghi, MA
    [J]. VACCINE, 1998, 16 (07) : 672 - 677
  • [38] SPECIFIC PROPHYLAXIS OF TETANUS
    EDSALL, G
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1959, 171 (04): : 417 - 427
  • [39] Development, acceptance, and use of immunologic correlates of protection in monitoring the effectiveness of combination vaccines
    Edwards, KM
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 : S274 - S277
  • [40] FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007
    Eichelberger, Maryna
    Golding, Hana
    Hess, Maureen
    Weir, Jerry
    Subbarao, Kanta
    Luke, Catherine J.
    Friede, Martin
    Wood, David
    [J]. VACCINE, 2008, 26 (34) : 4299 - 4303